Potential of improving the treatment of tuberculosis through nanomedicine

Molecular Crystals and Liquid Crystals

Volumn 556, Issue , 2012, Pages 317-330

  Semete, Boitumelo ^a   Kalombo, Lonji ^a   Katata, Lebogang ^a   Chelule, Paul ^a   Booysen, Laetitia ^a,b   Lemmer, Yolandy ^a   Naidoo, Saloshnee ^a   Ramalapa, Bathabile ^a   Hayeshi, Rose ^a   Swai, Hulda S ^a  

^a Future production Chemicals Cluster   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Drug release; Nanomedicine; PLGA nanoparticles; Tuberculosis

Indexed keywords

CURRENT TREATMENTS; DRUG DELIVERY SYSTEM; DRUG ENCAPSULATION EFFICIENCY; DRUG RELEASE; IN-VITRO; PLGA NANOPARTICLES; POLY LACTIC-CO-GLYCOLIC ACID; SINGLE-DOSE; SLOW RELEASE; SUSTAINED RELEASE; TUBERCULOSIS;

DRUG DELIVERY; DRUG DOSAGE; DRUG PRODUCTS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; SYNTHESIS (CHEMICAL);

TUBES (COMPONENTS);

EID: 84861548021     PISSN: 15421406     EISSN: 15635287     Source Type: Journal    
DOI: 10.1080/15421406.2012.635531     Document Type: Conference Paper

References (23)

1. WHO. (2007). World Health Statistics 2007.
2. WHO. (2007). Global tuberculosis control 2007: Key findings.
3. Wright,A., Bai, G., Barrera, L., Boulahbal, F.,Martin-Casabona,N., Gilpin, C., Drobniewski, F., Havelková, M., Lepe, R., Lumb, R., Metchock, B., Portaels, F., Rodrigues, M., Rüsch-Gerdes, S., van Deun, A., Vincent, V., Leimane, V., Riekstina, V., Skenders, G., Holtz, T., Pratt, R., Laserson, K., Wells, C., Cegielski, P., & Shah, N. S. (2004). Morbidity and Mortality Weekly Report.
4. Smith, P. J., van Dyk, J., & Fredericks, A. (1999). Int. J. Lung Dis., 3, 325.
5. Langer, R. (2000). Acc. Chem. Res., 33, 94.
6. Singh, B. N., & K. H. Kim, K. H. (2000). J. Control. Release, 63, 235.
7. Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995). Adv. Drug Deliv. Rev., 17, 31.
8. Farokhzad, O. C., & Langer, R. (2006). Adv. Drug Deliv. Rev., 58, 1456.
9. Torchilin, V. P. (2006). Adv. Drug Deliv. Rev., 58, 1532-1555.
10. Dutt, M., & Khuller, G. K. (2001). Antimicrob. Agents Chemother., 45, 363.
11. Pandey, R., Zahoor, A., Sharma, S., & Khuller, G. K. (2003). Tuberculosis, 83, 373.
12. Kisich, K. O., Gelperina, S., Higgins, M. P., Wilson, S., Shipulo, E., Oganesyan, E., & Heifets, L. (2007). Int. J. Pharm., 345, 154.
13. Lamprecht, A., Ubrich, N., Hombreiro Pérez, M., Lehr, C.-M., Hoffman, M., & Maincent, P. (1999). Int. J. Pharm., 184, 97.
14. Torchilin, V. P., & Trubetskoy, V. S. (1995). Adv. Drug Deliv. Rev., 16, 141.
15. Cui, F., Qian, F., & Yin, C. (2006). Int. J. Pharm., 316, 154.
16. Takeuchi, H., Thongborisute, J., Matsui, Y., Sugihara, H., Yamamoto, H., & Kawashima, Y. (2005). Adv. Drug Deliv. Rev., 57, 1583.
17. Mohan, B., Sharda, N., & Singh, S. (2003). J. Pharm. Biomed. Anal., 31, 607.
18. Jani, P. (1990). J. Pharm. Pharmacol., 42, 821.
19. Trewyn, B. G., Nieweg, J. A., Zhao, Y., & Lin, V. S. Y. (2008). Chem. Eng. J., 137, 23.
20. Dutt, M., & Khuller, G. K. (2001). J. Antimicrob. Chemother., 47, 829.
21. Ahlin, P., Kristl, J., Kristl, A., & Vrecer, F. (2002). Int. J. Pharm., 239, 113.
22. Siepmann, J., & Göpferich, A. (2001). Adv. Drug Deliv. Rev., 48, 229.
23. Ahsan, F., Rivas, I. P., Khan, M. A., & Torres Suβrez, A. I. (2002). J. Control. Release, 79, 29.